Correlation Between Inverse Nasdaq-100 and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Inverse Nasdaq-100 and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inverse Nasdaq-100 and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inverse Nasdaq 100 Strategy and Biotechnology Fund Class, you can compare the effects of market volatilities on Inverse Nasdaq-100 and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inverse Nasdaq-100 with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inverse Nasdaq-100 and Biotechnology Fund.
Diversification Opportunities for Inverse Nasdaq-100 and Biotechnology Fund
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inverse and Biotechnology is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Inverse Nasdaq 100 Strategy and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Inverse Nasdaq-100 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inverse Nasdaq 100 Strategy are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Inverse Nasdaq-100 i.e., Inverse Nasdaq-100 and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Inverse Nasdaq-100 and Biotechnology Fund
Assuming the 90 days horizon Inverse Nasdaq 100 Strategy is expected to under-perform the Biotechnology Fund. But the mutual fund apears to be less risky and, when comparing its historical volatility, Inverse Nasdaq 100 Strategy is 1.32 times less risky than Biotechnology Fund. The mutual fund trades about -0.07 of its potential returns per unit of risk. The Biotechnology Fund Class is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 6,851 in Biotechnology Fund Class on August 28, 2024 and sell it today you would lose (55.00) from holding Biotechnology Fund Class or give up 0.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inverse Nasdaq 100 Strategy vs. Biotechnology Fund Class
Performance |
| Timeline |
| Inverse Nasdaq 100 |
| Biotechnology Fund Class |
Inverse Nasdaq-100 and Biotechnology Fund Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inverse Nasdaq-100 and Biotechnology Fund
The main advantage of trading using opposite Inverse Nasdaq-100 and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inverse Nasdaq-100 position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.| Inverse Nasdaq-100 vs. Georgia Tax Free Bond | Inverse Nasdaq-100 vs. Morningstar Defensive Bond | Inverse Nasdaq-100 vs. Artisan High Income | Inverse Nasdaq-100 vs. T Rowe Price |
| Biotechnology Fund vs. Evaluator Conservative Rms | Biotechnology Fund vs. Lord Abbett Diversified | Biotechnology Fund vs. Pimco Diversified Income | Biotechnology Fund vs. Fidelity Advisor Diversified |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |